Biphosphonates on oncology;Bifosfonatos en oncología

Anales de Medicina Interna

Volumn 22, Issue 11, 2005, Pages 544-547

  Khosravi Shahi, Parham ^a   Diaz Munoz De La Espada V ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Bisphophonates; Breast cancer; Hypercalcemia of malignancy; Oncology; Osteoporosis

Indexed keywords

BIOPHOSPHONATE; DRUG ANALOG; PYROPHOSPHATE; UNCLASSIFIED DRUG; BISPHOSPHONIC ACID DERIVATIVE;

BIOAVAILABILITY; BONE DISEASE; BONE METASTASIS; BREAST CANCER; CONTROLLED STUDY; HUMAN; HYPERCALCEMIA; MEDICAL SOCIETY; METASTASIS; MULTIPLE MYELOMA; ONCOLOGY; ORGAN TRANSPLANTATION; OSTEOCLAST; OSTEOPOROSIS; PAGET BONE DISEASE; REVIEW; BONE TUMOR; BREAST TUMOR; NEOPLASM; PATHOLOGY;

BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; HUMANS; HYPERCALCEMIA; MULTIPLE MYELOMA; NEOPLASMS; OSTEOPOROSIS;

EID: 33644858315     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Fleisch H. Biphosphonates: mechanisms of action. Endocr Rev 1998; 19: 80-100.
2. Cheer SM, Noble S. Zolendronic acid. Drugs 2001; 61: 799-805.
3. Cyer B, Bauer DC. Oral biphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc 2002; 77: 1031-43.
4. Pelayo M, Agra Y. Bifosfonatos en la prevención de la osteoporosis de mujeres posmenopáusicas con baja masa ósea. Med Clin (Barc) 2004; 122: 304-10.
5. Delmas PD, Meunier PJ. The managment of Paget's disease of bone. N Engl J Med 1997; 336: 558-66.
6. Watts NB. Treatment of osteoporosis with biphosphonates. Rheum Dis Clin North Am 2001; 27: 197-214.
7. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med 1998; 104: 459-69.
8. Falk MJ, Heeger S, Lynch KA, Decaro KR, Bohach D, Gibson Ks, et al. Intravenous biphosphonate therapy in children with osteogenesis imperfecta. Pediatrics 2003; 111: 573-8.
9. Berenson JR. Treatment of hypercalcemia of malignancy with biphosphonates. Semin Oncol 2002; 29: 12-8.
10. Coleman RE. Biphosphonates for the prevention of bone metastases. Semin Oncol 2002; 29: 43-9.
11. Ralston SH, Gallagher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality: clinical experience in 126 treated patients. Ann Intern Med 1990; 112: 499-504.
12. Stewart AF. Hypercalcemia associated with Cancer. N Engl J Med 2005;352: 373-379.
13. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350: 1655-64.
14. Horwitz MJ, Stewart AF. Humoral hypercalcemia of malignancy. In: Favus MF,ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington D.C. Am Soc Bone Min Res, 2003: 246-50.
15. Hernández JL, Riancho JA, González J. Bifosfonatos intravenosos. Med Clin (Barc) 2005; 124: 384-54.
16. Major P, Lortholary A, Hon J. Zolendronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized controlled clinical trials. J Clin Oncol 2001; 19: 558-67.
17. Wong R, Wiffen PJ. Biphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002; 2: CD002068.
18. Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA et al. American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women with breast cancer. J Clin Oncol 2003; 21: 4042-4057.
19. Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC et al. American Society of Clinical Oncology practice guidelines: The role of bisphosphonates in multiple myeloma. J Clin Oncol 2002; 17: 3719-3736.
20. Rosen LS, Gordon D, Kaminski M. Zolendronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J 2001; 7: 377-387.
21. Saarto T, Blomqvist C, Virkkunen P. No reduction of bony metastases with adjuvant clodronate treatment in node-positive breast cancer patients. J Clin Oncol 2001; 19: 10-17.
22. Powles T, Paterson S. Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 2002; 20: 3219-3224.
23. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med 2004; 351: 1860-73.